BACK TO MAIN ACCUMULATION OF PERFLUOROOCTANESULFONATE AND RELATED FLUOROCHEMICALS IN FISH TISSUES John P.

BACK TO MAIN Study Title Microbial Metabolism (Biodegradation) Studies of Perfluorooctane Sulfonate (PFOS) II.

3M Medical Department Study: T6316.1 3M Medical Department Study: T-6316.1 Analytical Report: FACT-TOX-001 LRN-U2103 Analytical Report: FACLTRTNO-UX2-010013 Study Title 104-Week Dietary Carcinogenicity Study with Narrow Range (98.1%) N-Ethyl Perfluorooctanesulfonamido Ethanol in Rats Analytical Laboratory Report Title Determination of the Presence and Concentration of PFOS, PFOSA, PFOSAA, EtFOSE-OH, M556, and PFOSEA in Serum and Liver Samples of Crl:CD(SD) IGS BR Rats Exposed to N-Ethyl Perfluorooctanesulfonamido Ethanol Data Requirement Not Applicable Author 3M Environmental Laboratory Study Completion Date June 06, 2001 Performing Laboratories Liver and Serum Analyses 3M Environmental Laboratory Building 2-3E-09, 935 Bush Avenue St.

00 f t I Z I O - / H NOTE TO FILE - AR 226/OPPTS 50639 DATE: March 14, 2001 FROM: Karen Lannon SUBJECT: 1/4/01 Meeting with Department of Defense (DoD) concerning Aqueous Film Forming Foam (AFFF) A meeting was held on January 4, 2001 to discuss alternatives to PFOS-based AFFF and possible DoD plans for transitioning away from PFOS-based AFFF.

COMPANY SANITIZED 17 Dec 2001 RECEIVED 0PPT CP.IC 01 DEC18 PH |: It) Telomer Research Program Update and Status Report United States Environmental Protection Agency 18 December 2001 Telomer Research Program Company Sanitized.

Executive Summary - Biodegradation Screening Studies of 8-2 Telomer B Alcohol - The two studies described in the attached reports (EMSER 13-03/4842 and EMSER 15-03/4842) represent the screening phase for the biodegradability assessment of 8-2 Telomer B Alcohol (CAS# 678-39-7).

NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 606-331-2838 513-381-2838 FAX: 513-381-6613 DAYTON, OHIO OFFICE SUITE 900 110 NORTH MAIN STREET DAYTON, OHIO 45402-1786 937-228-2838 FAX: 937-228-2816 Robert A.

!

ZaceAnalytical Enclosure 2 Field Services Division M 3-A 6-. l ?

ATTACHMENT TO LETTER OF 12/05/05 3M FLUOROCHEMICAL SUBMISSION BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE Click on Study Title to View Report Multiple Chemicals 1.

SRJPTT-6295.8, T-6316,4, T-6868.2, T-7071.1, T-7132.1 0T15-B 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY T-6295), N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316), N-Ethyl perfluorooctanesuifonamide (N -ItFO SA , T-6868), Perflu orooctan esu Ifonamido acetate (FOSAA, T-7071), and/or Perfluorooctanesulfonam ide (FOSA , T-7132) o f in Rats and Guinea Pigs following O ral dosing.

REPORT Study Title ASSESSMENT OF ACUTE ORAL TOXICITY WITH T-7868 IN THE RAT (ACUTE TOXIC CLASS METHOD) Author Drs.

January 2005 Supplemental Notice of Contamination A /?

4r* 226-2047 Roger J Zipfel 07/27/2001 01:30 PM To: John E Crum/SE/DuPont@DuPont cc: Ta-W ei Fu/CL/DuPont@DuPont Subject Re: C-8 sampling Q John, this is very perplexing information.

AR226-2188 ,3 Debbie J Mulrooney ' 08/23/2001 09:53 A M To: cc: Subject Chris E Shoop/AE/DuPont@DuPont Question on Source Spreadsheet Chris, I noticed that on the revised spreadsheet you added a column showing the fraction of P M that is C8.